ArticleBMJ open2024

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial.

Elisabeth Bahlmann-Kroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.